Caxton Associates (New York)’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Other funds holding HCA
Caxton Associates (New York)'s HCA Position: Q4 2024 in Review
Caxton Associates (New York) reduced its HCA Healthcare (HCA) stake by 34% in Q4 2024, selling an estimated $505K and leaving 2,844 shares worth $854K. The position accounts for 0.03% of the portfolio, ranked #244.
Caxton Associates (New York) first reported a position in HCA in Q4 2013 and has held it in 15 quarters since. The position peaked at $42.9M in Q4 2013. 1,180 funds tracked by Wall St. Rank hold HCA as of Q4 2024.
- Caxton Associates (New York) held 2,844 shares of HCA Healthcare worth $854K as of Q4 2024.
- Caxton Associates (New York) sold 1,444 HCA Healthcare shares in Q4 2024, an estimated $505K.
- HCA Healthcare made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #244 holding.
- Caxton Associates (New York) first reported a position in HCA Healthcare in Q4 2013 and has held it in 15 quarters since.
- Caxton Associates (New York)'s HCA Healthcare position peaked at $42.9M in Q4 2013.
- 1,180 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.